Multiple system atrophy

  • W. H. Oertel
  • O. Bandmann
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 56)


Multiple system atrophy (MSA) is a degenerative central nervous system disease of unclear origin. Patients affected typically show symptoms attributable to the combined involvement of the extrapyramidal, pyramidal, cerebellar and autonomic nervous systems. At onset patients mostly see a doctor because of extrapyramidal or — more rarely — cerebellar symptoms. Evidence of autonomic nervous system involvement is often not apparent, at least to the neurologist, before the history is taken. In later stages, by contrast, involvement of all of the above systems is clinically detectable.


Multiple System Atrophy Neurol Neurosurg Psychiatry Progressive Supranuclear Palsy Spinocerebellar Ataxia Multiple System Atrophy Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abbruzese G, Marchese R, Trompetto C (1997) Sensory and motor evoked potentials in multiple system atrophy: a comparative study with Parkinson’s disease. Mov Disord 12: 315–321CrossRefGoogle Scholar
  2. Bandmann O, Wenning GK, Quinn NP, Harding AE (1995) Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy. J Neurol Neurosurg Psychiatry 59: 557PubMedCrossRefGoogle Scholar
  3. Bandmann O, Vaughan J, Holmans P, Marsden C, Wood N (1997) Multiple system atrophy is genetically distinct from identified hereditary causes of spinocerebellar degeneration. Neurology 9: 1598–1604CrossRefGoogle Scholar
  4. Bannister R, Mowbray J, Sidgwick A (1983) Genetic control of progressive autonomic failure: evidence for an association with an HLA antigen. Lancet 1: 1017PubMedCrossRefGoogle Scholar
  5. Benecke R, Struemper P, Weiss H (1993) Electron transfer complexes I and IV of platelets are abnormal in Parkinson’s disease but normal in Parkinson-plus syndromes. Brain 116: 1451–1463PubMedCrossRefGoogle Scholar
  6. Ben Shlomo Y, Wenning GK, Tison F, Quinn NP (1997) Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 48: 384–393PubMedCrossRefGoogle Scholar
  7. Blin O, Desnuelle C, Rascol O, Borg M, Peyro Saint Paul H, Azulay J, Bille F, Figarella D, Coulom F, Peillissier J (1994) Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson’s disease and multiple system atrophy. J Neurol Sci 125: 95–101PubMedCrossRefGoogle Scholar
  8. Brooks D, Ibanez V, Sawle GC, Quinn N, Lees AJ, Bannister R, Marsden CD, Frackowiak RS (1990) Differing patterns of striatal 18F-dopa uptake in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol 28: 547–555PubMedCrossRefGoogle Scholar
  9. Cohen G (1994) The brain on fire? Ann Neurol 36: 333–334PubMedCrossRefGoogle Scholar
  10. Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 41: 277–281PubMedCrossRefGoogle Scholar
  11. Daniel S, Geddes J, Revesz T (1995) Glial cytoplasmic inclusions are not exclusive to multiple system atrophy. J Neurol Neurosurg Psychiatry 58: 262PubMedCrossRefGoogle Scholar
  12. Dexter D, Carayon A, Javoy-Agid F, Agid Y, Wells F, Daniel S, Lees A, Jenner P, Marsden C (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson’s disease and other neurodegenerative diseases affecting the basal ganglia. Mov Disord 114: 1953–1975Google Scholar
  13. Eardley I, Quinn NP, Fowler CJ, Kirby RS, Parkhouse HF, Marsden CD, Bannister R (1989): The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. Brit J Urol 64: 360–362PubMedCrossRefGoogle Scholar
  14. Gilman S, Sima A, Junck L, Kluin K, Koeppe R, Lohman M, Little R (1996) Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions. Ann Neurol 39: 241–255PubMedCrossRefGoogle Scholar
  15. Giunti P, Sweeney M, Harding A (1995) Detection of the Machado-Joseph disease/ spinocerebellar ataxia three trinucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walworth. Brain 118: 1077–1085PubMedCrossRefGoogle Scholar
  16. Goldstein DS, Holmes C, Cannon RO, Eisenhofer G, Kopin IJ (1997) Sympathetic cardioneuropathy in dysautonomias. NEJM 336: 696–702PubMedCrossRefGoogle Scholar
  17. Graham J, Oppenheimer D (1969): Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 32: 28–34PubMedCrossRefGoogle Scholar
  18. Iwahashi K, Miyatake R, Tsuneoka Y, Matsuo Y, Ichikawa Y, Hosokawa K, Sato K, Hayabara T (1995) A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy. J Neurol Neurosurg Psychiatry 58: 263–264PubMedCrossRefGoogle Scholar
  19. Lantos P, Papp M (1994) Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 57: 129–133PubMedCrossRefGoogle Scholar
  20. Leiguarda RC, Pramstaller PP, Merello M, Starkstein S, Lees AJ, Marsden CD (1997) Apraxia in Parkinson’s disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism, Brain 120: 75–90PubMedCrossRefGoogle Scholar
  21. Nee L, Gomey M, Dambrosia J, Bale S, Eldridge R, Polinski R (1991) Enviromental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin Auton Res 1: 9–13PubMedCrossRefGoogle Scholar
  22. Olanow C (1993) A radical hypothesis for neurodegeneration. Trends Neurosci 16: 439–444PubMedCrossRefGoogle Scholar
  23. Palace J, Chandiramani VA, Fowler CJ (1997): Value of sphincter electromyography in the diagnosis of multiple system atrophy. Muscle Nerve 20: 1396–1403PubMedCrossRefGoogle Scholar
  24. Parkinson J (1817): An essay on the shaking palsy. Sherwood, Neely and Jones, LondonGoogle Scholar
  25. Pramstaller P, Wenning GK, Smith SJ, Beck RO, Quinn NP, Fowler CJ (1995) Nerve conduction studies, skeletal muscle EMG, and sphincter EMG in multiple system atrophy. JNNP 58: 618–621Google Scholar
  26. Quinn N (1989) Multiple system atrophy — the nature of the beast. J Neurol Neurosurg Psychiatry 52: 78–89CrossRefGoogle Scholar
  27. Quinn N (1994): Multiple system atrophy. In: Marsden C, Fahns S (eds) Movement disorders 3. Butterworth-Heinemann, London, S262–281Google Scholar
  28. Robbins TW, James M, Lange KW, Owen AM, Quinn NP, Marsden CD (1992) Cognitive performance in multiple system atrophy. Brain 115: 271–291PubMedCrossRefGoogle Scholar
  29. Schapira AHV, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) Anatomic and disease specificity of NADH CoQl reductase (complex I) deficiency in Parkinson’s disease. J Neurochem 55: 2142–2145PubMedCrossRefGoogle Scholar
  30. Schwarz J, Tatsch K, Arnold G, Gasser T, Trenkwalder C, Kirsch CM, Oertel WH (1992) 123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology 42: 556–561PubMedCrossRefGoogle Scholar
  31. Schwarz J, Weis S, Kraft E, Tatsch K, Bandmann O, Mehraein P, Vogl T, Oertel W (1996) Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 60: 98–101PubMedCrossRefGoogle Scholar
  32. Schwarz J, Kornhuber M, Bischoff C, Straube A (1997) Electromyography of the external anal sphincter in patients with Parkinson’s disease and multiple system atrophy: frequency of abnormal spontaneous activity and polyphasic motor unit potentials. Muscle Nerve 20: 1167–1172PubMedCrossRefGoogle Scholar
  33. Shulman L, Weiner W (1997) Multiple system atrophy. In: Watts R, Kollers W (eds): Movement disorders: neurologic principles and practice. McGraw-Hill, New York, pp 297–304Google Scholar
  34. Shy G, Drager G (1960) A neurologic syndrome associated with orthostatic hypotension. Arch Neurol 2: 511–527PubMedCrossRefGoogle Scholar
  35. Sian J, Dexter D, Lees A, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden C (1994a) Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting the basal ganglia. Ann Neurol 36: 348–355PubMedCrossRefGoogle Scholar
  36. Sian J, Dexter D, Lees A, Daniel S, Jenner P, Marsden C (1994b) Glutathione-related enzymes in brain in Parkinson’s disease. Ann Neurol 36: 356–361PubMedCrossRefGoogle Scholar
  37. Stauffenberg V (1918): Zur Kenntnis des extrapyramidalen motorischen Systems und Mitteilung eines Falles von sog. “Atrophie olivo-pontocerebelleuse”, Z Gesamte Neurol Psychiatrie 39: 1–55CrossRefGoogle Scholar
  38. Swerdlow R, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP, Davis RE, Parker WD (1997) As in Parkinson’s disease, a bioenergetic defect transfers with mitochondrial DNA of patients with multisystem atrophy. Mov Disord 12 S1: 3Google Scholar
  39. Valldeoriola F, Valls-Sole J, Tolosa ES, Marti MJ (1995) Striated anal sphincter denervation in patients with progressive supranuclear palsy. Mov Disord 10: 550–555PubMedCrossRefGoogle Scholar
  40. Wenning G, Ben Shlomo Y, Magalhaes M, Daniel S, Quinn N (1994a) Clinical features and history of multiple system atrophy. Brain 117: 835–845PubMedCrossRefGoogle Scholar
  41. Wenning G, Jager R, Kendall B, Kingsley D, Daniel SE, Quinn NP (1994b) Is cranial computerized tomography useful in the diagnosis of multiple system atrophy? Mov Disord 9: 333–336PubMedCrossRefGoogle Scholar
  42. Wenning G, Tison F, Elliott L, Quinn NP, Daniel SE (1996) Olivopontocerebellar pathology in multiple system atrophy. Mov Disord 11: 157–162PubMedCrossRefGoogle Scholar
  43. Wood N (1997) Genes and parkinsonism. J Neurol Neurosurg Psychiatry 62: 305–309PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 1999

Authors and Affiliations

  • W. H. Oertel
    • 1
  • O. Bandmann
    • 1
  1. 1.Department of NeurologyPhilipps-University MarburgMarburgFederal Republic of Germany

Personalised recommendations